In conclusion, we believe that these five target genes (GSK3B, CDC20, TPX2, AURKA and CCNE1) may promote the occurrence of bladder cancer and lead to poor prognosis.We explored the potential therapeutic targets of aspirin for bladder cancer by comprehensive bioinformatics analysis. This evidence concerns the gene TPX2 and urinary bladder cancer.